English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT02343042 /

KCP-330-017

A Phase 1b/2 Study Of Selinexor (KPT-330) In Combination With Backbone Treatments For Relapsed/Refractory Multiple Myeloma

DISEASE GROUP:
Multiple Myeloma
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: